Correlation Between MedMira and Neurobiological Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MedMira and Neurobiological Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MedMira and Neurobiological Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MedMira and Neurobiological Technologies, you can compare the effects of market volatilities on MedMira and Neurobiological Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MedMira with a short position of Neurobiological Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of MedMira and Neurobiological Technologies.

Diversification Opportunities for MedMira and Neurobiological Technologies

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between MedMira and Neurobiological is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding MedMira and Neurobiological Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurobiological Technologies and MedMira is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MedMira are associated (or correlated) with Neurobiological Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurobiological Technologies has no effect on the direction of MedMira i.e., MedMira and Neurobiological Technologies go up and down completely randomly.

Pair Corralation between MedMira and Neurobiological Technologies

If you would invest  5.32  in MedMira on September 15, 2024 and sell it today you would earn a total of  0.18  from holding MedMira or generate 3.38% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.79%
ValuesDaily Returns

MedMira  vs.  Neurobiological Technologies

 Performance 
       Timeline  
MedMira 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in MedMira are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, MedMira may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Neurobiological Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Neurobiological Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong forward indicators, Neurobiological Technologies is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

MedMira and Neurobiological Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MedMira and Neurobiological Technologies

The main advantage of trading using opposite MedMira and Neurobiological Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MedMira position performs unexpectedly, Neurobiological Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurobiological Technologies will offset losses from the drop in Neurobiological Technologies' long position.
The idea behind MedMira and Neurobiological Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation